Table 2

Baseline characteristics of survivors and non-survivors

Survivors
(n=67)
Non-survivors (n=15)P values
Maternal age (years)22.6±3.024.0±1.80.37
Gestational age (weeks)38.8±1.338.0±1.20.14
Age at start of cooling (hours)3.6±1.44.1±1.40.22
Birth weight (g)2912±3642855±3880.58
Head circumference (cm)33.7±0.833.9±0.40.49
1 min Apgar—median (IQR)1 (0)2 (2)0.33
5 min Apgar— median (IQR)4 (0)4.5 (2)0.60
10 min Apgar— median (IQR)5.0 (0)5.0 (0)0.36
20 min Apgar— median (IQR)7.0 (0)NA
Gender (male)45/66 (68%)8/15 (53%)0.37
Severe encephalopathy11/67 (16%)10/15 (67%)<0.001
Seizures within 6 hours of birth55/64 (86%)13/14 (93%)0.68
Complications in pregnancy4/64 (6%)1/12 (8%)1.00
Complications during delivery9/64 (14%)0/13 (0%)0.34
Meconium stained liquor13/60 (22%)6/11 (55%)0.06
Maternal fever during labour2/64 (3%)1/13 (8%)0.43
Place of delivery
 Inborn15/65 (23%)4/13 (31%)
 Outborn— hospital48/65 (74%)9/13 (69%)0.81
 Outborn— home2/65 (3%)0/13 (0%)
Delivery method
 Prelabour LSCS2/65 (3%)0/13 (0%)
 Emergency LSCS6/65 (9%)2/13 (15%)0.82
 Spontaneous vaginal delivery55/65 (85%)13/13 (85%)
 Instrumental vaginal delivery2/65 (3%)0/13 (0%)
Neonatal complications
 Gastric bleeds14/38 (37%)11/11 (100%)<0.001
 Pulmonary haemorrhage1/38 (3%)5/11 (45%)0.001
 PPHN1/38 (3%)6/11 (55%)<0.001
 Thrombocytopenia42/67 (63%)10/15 (67%)1.00
 Metabolic acidosis26/67 (39%)9/15 (60%)0.16
Treatment duration (days)
 Invasive ventilation1.4±1.83.3±1.50.002
 Sedation0.9±1.51.4±1.80.40
 Inotropic support3.1±1.33.9±0.30.04
 Anticonvulsive drugs2.9±1.73.9±0.30.07
  • LSCS, lower segment caesarean section; PPHN, persistent pulmonary hypertension.

  • Mean values ± SD or proportion (percentage), unless specified otherwise.